Special K

Long suicidal, Joe Wright “almost immediately started feeling more hopeful about life” after taking Ketamine as part of a small Columbia University study.

The infamous party drug has shown remarkable results in quelling suicidal thoughts—so why hasn’t it gone mainstream? In part, testing drugs—and placebos—on suicidal patients is risky territory for Big Pharma, and researching an “old, cheap drug” offers little financial incentive.

But as suicides rise in the US, a new round of drugs is putting the old patent to use. The first ketamine-based drug for suicidal thoughts could be available within 2 years.

Bloomberg Businessweek

Comments +

0 comments

Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top